|
1
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Banerjee S, Modi S, McGinn O, Zhao X,
Dudeja V, Ramakrishnan S and Saluja AK: Impaired synthesis of
stromal components in response to minnelide improves vascular
function, drug delivery and survival in pancreatic cancer. Clin
Cancer Res. 22:415–425. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen DS and Mellman I: Oncology meets
immunology: The cancer-immunity cycle. Immunity. 39:1–10. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ott PA, Hodi FS and Robert C: CTLA-4 and
PD-1/PD-L1 blockade: New immunotherapeutic modalities with durable
clinical benefit in melanoma patients. Clin Cancer Res.
19:5300–5309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brahmer JR, Drake CG, Wollner I, Powderly
JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, McMiller
TL, et al: Phase I study of single-agent anti-programmed death-1
(MDX-1106) in refractory solid tumors: Safety, clinical activity,
pharmacodynamics and immunologic correlates. J Clin Oncol.
28:3167–3175. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Topalian SL, Hodi FS, Brahmer JR,
Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD,
Sosman JA, Atkins MB, et al: Safety, activity and immune correlates
of anti-PD-1 antibody in cancer. N Engl J Med. 366:2443–2454. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
El-Asady R, Yuan R, Liu K, Wang D, Gress
RE, Lucas PJ, Drachenberg CB and Hadley GA: TGF-{beta}-dependent
CD103 expression by CD8+ T cells promotes selective destruction of
the host intestinal epithelium during graft-versus-host disease. J
Exp Med. 201:1647–1657. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kilshaw PJ and Murant SJ: A new surface
antigen on intraepithelial lymphocytes in the intestine. Eur J
Immunol. 20:2201–2207. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Evers BD, Engel DR, Böhner AM, Tittel AP,
Krause TA, Heuser C, Garbi N, Kastenmuller W, Mack M, Tiegs G, et
al: CD103+ kidney dendritic cells protect against crescentic GN by
maintaining IL-10-producing regulatory t cells. J Am Soc Nephrol.
27:3368–3382. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Floc'h AL, Jalil A, Vergnon I, Le Maux
Chansac B, Lazar V, Bismuth G, Chouaib S and Mami-Chouaib F: Alpha
E beta 7 integrin interaction with E-cadherin promotes antitumor
CTL activity by triggering lytic granule polarization and
exocytosis. J Exp Med. 204:559–570. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Djenidi F, Adam J, Goubar A, Durgeau A,
Meurice G, de Montpréville V, Validire P, Besse B and Mami-Chouaib
F: CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific
tissue-resident memory T cells and a prognostic factor for survival
in lung cancer patients. J Immunol. 194:3475–3486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Le Floc'h A, Jalil A, Franciszkiewicz K,
Validire P, Vergnon I and Mami-Chouaib F: Minimal engagement of
CD103 on Cytotoxic T lymphocytes with an E-cadherin-Fc molecule
triggers lytic granule polarization via a phospholipase
Cgamma-dependent pathway. Cancer Res. 71:328–338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jonasch E, Gao J and Rathmell WK: Renal
cell carcinoma. BMJ. 349:g47972014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sharma P, Wagner K, Wolchok JD and Allison
JP: Novel cancer immunotherapy agents with survival benefit: Recent
successes and next steps. Nat Rev Cancer. 11:805–812. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cohen M: Comparing relaxation training and
cognitive-behavioral group therapy for women with breast cancer.
Res Social Work Pract. 17:313–323. 2007. View Article : Google Scholar
|
|
17
|
Chan AC, Fan ST, Poon RT, Cheung TT, Chok
KS, Chan SC and Lo CM: Evaluation of the seventh edition of the
American Joint Committee on Cancer tumour-node-metastasis (TNM)
staging system for patients undergoing curative resection of
hepatocellular carcinoma: Implications for the development of a
refined staging system. HPB (Oxford). 15:439–448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao X, He Y and Chen H: Autophagic tumor
stroma: Mechanisms and roles in tumor growth and progression. Int J
Cancer. 132:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Broz ML, Binnewies M, Boldajipour B,
Nelson AE, Pollack JL, Erle DJ, Barczak A, Rosenblum MD, Daud A,
Barber DL, et al: Dissecting the tumor myeloid compartment reveals
rare activating antigen-presenting cells critical for T cell
immunity. Cancer Cell. 26:638–652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Salmon H, Idoyaga J, Rahman A, Leboeuf M,
Remark R, Jordan S, Casanova-Acebes M, Khudoynazarova M, Agudo J,
Tung N, et al: Expansion and activation of CD103+ dendritic cell
progenitors at the tumor site enhances tumor responses to
therapeutic PD-L1 and BRAF inhibition. Immunity. 44:924–938. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Webb JR, Milne K and Nelson BH: Location,
location, location: CD103 demarcates intraepithelial,
prognostically favorable CD8+ tumor-infiltrating lymphocytes in
ovarian cancer. Oncoimmunology. 3:e276682014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang B, Wu S, Zeng H, Liu Z, Dong W, He W,
Chen X, Dong X, Zheng L, Lin T and Huang J: CD103+ tumor
infiltrating lymphocytes predict a favorable prognosis in
urothelial cell carcinoma of the bladder. J Urol. 194:556–562.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Y and Cao X: Intratumoral dendritic
cells in the anti-tumor immune response. Cell Mol Immunol.
12:387–390. 2015. View Article : Google Scholar : PubMed/NCBI
|
